Verwendung eines Kombinationsproduktes enthaltend einen kompetitiven Progesteronantagonisten und ein Gestagen zur Herstellung eines Arzneimittels zur Behandlung der Endometriose oder des Leiomyomata uteri
摘要
The present invention concerns the use of a product containing in combination individual dosage units of a competitive progesterone antagonist and individual dosage units of a gestagen to be sequentially orally administrated (the competitive progesterone antagonist being present in each individual dosage unit in quantities not capable of inducing miscarriage) to produce a medicament for use in the treatment of endometriosis or leiomyomata uteri.